Related Experiment Video
Updated: Apr 5, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mast Cell Activation Syndrome and Mimickers.
Curie Ahn1, César Alberto Galván Calle2, Jonathan A Bernstein3
1Department of Medicine, Westchester Medical Center, New York Medical College, 100 Woods Road, Valhalla, NY 10595, USA.
Mast cell activation syndrome (MCAS) is a complex condition that often leaves patients feeling unheard by clinicians. Accurate patient characterization, including ruling out mimicking conditions, is crucial for effective MCAS management.
Area of Science:
- Allergy and Immunology
- Clinical Medicine
Background:
- Mast cell activation syndrome (MCAS) is a prevalent but challenging condition managed by allergists-immunologists.
- Patients frequently report feeling dismissed, leading to fragmented care and multiple specialist visits.
- Accurate diagnosis and characterization are essential for optimal patient outcomes.
Purpose of the Study:
- To highlight the challenges in diagnosing and managing MCAS.
- To emphasize the importance of accurate patient assessment in MCAS care.
- To guide clinicians in providing consistent and compassionate care for MCAS patients.
Main Methods:
- Review of clinical presentation and diagnostic considerations in MCAS.
- Discussion of coexisting conditions that mimic or confound MCAS diagnosis.
- Analysis of patient experiences and healthcare-seeking behaviors.
Main Results:
- MCAS diagnosis is often complicated by its varied presentation and overlapping symptoms with other conditions.
- Patients often experience significant delays in diagnosis and treatment due to feeling unheard.
- Identifying and addressing confounding conditions is key to successful MCAS management.
Conclusions:
- Clinicians require enhanced strategies to effectively diagnose and manage MCAS.
- A thorough patient evaluation, including assessment for mimicking conditions, is paramount.
- Improving patient communication and care coordination can significantly enhance outcomes for individuals with MCAS.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Toxidromes: Clinical Features
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Nonconscious Mimicry
Allergic Reactions
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...

